de Melo Campos, P., Machado-Neto, J. A., Lorand-Metze, I., Costa, F. F., Olalla Saad, S. T., & Traina, F. (2018). IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes. Hematol Transfus Cell Ther.
Citação norma Chicagode Melo Campos, Paula, João Agostinho Machado-Neto, Irene Lorand-Metze, Fernando Ferreira Costa, Sara Teresinha Olalla Saad, and Fabiola Traina. "IRAK1 Expression in Bone Marrow Cells Does Not Impact Patient Outcomes in Myelodysplastic Syndromes." Hematol Transfus Cell Ther 2018.
ציטוט MLAde Melo Campos, Paula, et al. "IRAK1 Expression in Bone Marrow Cells Does Not Impact Patient Outcomes in Myelodysplastic Syndromes." Hematol Transfus Cell Ther 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.